Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease
NCT05582447 is an observational study sponsored by Children's Hospital Medical Center, Cincinnati. As of 21 Nov 2026, it is active and no longer recruiting. It studies Cholestasis and Red Cell Membrane and Enzyme Abnormalities. The registry lists an enrollment of 40 participants at 1 site in 1 country. The registry lists a start date of 17 Apr 2018 and a primary completion date of 31 Dec 2026.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT05582447 |
| Status | Active not recruiting |
| Study type | Observational study |
| Lead sponsor | Children's Hospital Medical Center, Cincinnati |
| Enrollment | 40 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Cholestasis and Red Cell Membrane and Enzyme Abnormalities |
| Start | 17 Apr 2018 |
| Primary completion | 31 Dec 2026 |
| Study completion | 31 Dec 2027 |
| Last update posted | 6 Feb 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Samuel A Kocoshis, MD
Children's Hospital Medical Center, Cincinnati
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cincinnati Children's Hospital Medical Center
Cincinnati
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT05582447
Each answer restates registry values shown on this page.
What is NCT05582447?
NCT05582447 is an observational study sponsored by Children's Hospital Medical Center, Cincinnati. It studies Cholestasis and Red Cell Membrane and Enzyme Abnormalities.
Is NCT05582447 recruiting?
As of 21 Nov 2026, it is active and no longer recruiting.
Who leads NCT05582447?
The registry names Samuel A Kocoshis, MD (principal investigator, Children's Hospital Medical Center, Cincinnati) as the overall official.
Where does NCT05582447 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT05582447 expected to complete?
The registry lists a primary completion date of 31 Dec 2026 and a study completion date of 31 Dec 2027. The sponsor last updated the record on 6 Feb 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.